COVID-19

An update on Pharma To Market’s response to COVID-19

Update 24 March 2020: All of our Australian & Malaysian-based team members are working from home.  No disruptions to our services are anticipated however some delays in dispatching materials via post or courier may be experienced. Office phone numbers have been redirected, so please continue to contact us via normal channels. Our team will be in touch if this is likely to affect your projects.

 Dear Valued Clients and Partners,

With Covid-19 happening around the world, we have all had to deal with the impact and uncertainty surrounding our communities and our businesses.  Our thoughts go out to everyone directly affected by the current situation.

For over 10 years, Pharma To Market has focused on our vision through our commitment to customer service, quality, and knowledge in our fields of expertise. With this vision in mind, we have implemented our business continuity plans to ensure continued service to our clients.

For many years, our team members have operated via encrypted access to our secure and robust remote environment, providing our teams with access to all business applications, web services and file servers on a platform certified against ISO 27001:2013 ‘Information Security Management System’.  We’ve implemented communication tools and have assessed and tested home office infrastructure for all personnel in order to avoid any major disruptions to our operations in the event that our people need to work from home. We are fully equipped and prepared to maintain business as usual services across our regional business with these IT setups.

Following the guidance of World Health Organization, as well as directives from local governments, we are assessing the situation on a daily basis and as necessary will allow employees to work remotely. In addition, all business travel has been temporarily suspended.

Currently, we are operating as per normal across all our countries and will continue delivering our services to you with minimal disruption.

We have put these measures in place to ensure the health and safety of our people and their families, as well as to minimize any impact to our services, so that you continue to receive the quality and support that we know you have always counted on Pharma To Market to deliver.

Our leadership team will continue to closely monitor, assess and adapt to any changing circumstances.

From all of us at Pharma To Market, we hope you stay safe and healthy, and please do not hesitate to contact us if you have any concerns.

 

Nick, Johanna and Joelle

Co-Directors of Pharma To Market